Amgen Inc (AMGN)
273.01
-0.53
(-0.19%)
USD |
NASDAQ |
Apr 24, 16:00
275.00
+1.99
(+0.73%)
After-Hours: 20:00
Amgen Debt to Equity Ratio: 10.37 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | 10.37 |
| September 30, 2023 | 7.898 |
| June 30, 2023 | 9.076 |
| March 31, 2023 | 11.52 |
| December 31, 2022 | 10.64 |
| September 30, 2022 | 10.60 |
| June 30, 2022 | 15.10 |
| March 31, 2022 | 40.23 |
| December 31, 2021 | 4.972 |
| September 30, 2021 | 4.573 |
| June 30, 2021 | 3.975 |
| March 31, 2021 | 3.502 |
| December 31, 2020 | 3.506 |
| September 30, 2020 | 3.129 |
| June 30, 2020 | 3.211 |
| March 31, 2020 | 3.358 |
| December 31, 2019 | 3.091 |
| September 30, 2019 | 2.726 |
| June 30, 2019 | 2.836 |
| March 31, 2019 | 3.049 |
| December 31, 2018 | 2.714 |
| September 30, 2018 | 2.399 |
| June 30, 2018 | 2.314 |
| March 31, 2018 | 2.275 |
| December 31, 2017 | 1.400 |
| Date | Value |
|---|---|
| September 30, 2017 | 1.110 |
| June 30, 2017 | 1.105 |
| March 31, 2017 | 1.113 |
| December 31, 2016 | 1.158 |
| September 30, 2016 | 1.148 |
| June 30, 2016 | 1.102 |
| March 31, 2016 | 1.196 |
| December 31, 2015 | 1.119 |
| September 30, 2015 | 1.136 |
| June 30, 2015 | 1.163 |
| March 31, 2015 | 1.145 |
| December 31, 2014 | 1.192 |
| September 30, 2014 | 1.302 |
| June 30, 2014 | 1.367 |
| March 31, 2014 | 1.408 |
| December 31, 2013 | 1.454 |
| September 30, 2013 | 1.251 |
| June 30, 2013 | 1.161 |
| March 31, 2013 | 1.226 |
| December 31, 2012 | 1.392 |
| September 30, 2012 | 1.330 |
| June 30, 2012 | 1.267 |
| March 31, 2012 | 1.134 |
| December 31, 2011 | 1.126 |
| September 30, 2011 | 0.6057 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
2.726
Minimum
Sep 2019
40.23
Maximum
Mar 2022
8.121
Average
4.573
Median
Sep 2021
Debt to Equity Ratio Benchmarks
| Gilead Sciences Inc | 1.094 |
| Johnson & Johnson | 0.4265 |
| Eli Lilly and Co | 2.342 |
| Merck & Co Inc | 0.9328 |
| Vertex Pharmaceuticals Inc | 0.00 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 97.15B |
| Total Liabilities (Quarterly) | 90.92B |
| Shareholders Equity (Quarterly) | 6.232B |
| Current Ratio | 1.649 |
| Net Debt Paydown Yield | -3.36% |